Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors

Pediatric and Developmental Pathology

Volumn 15, Issue SUPPL. 1, 2012, Pages 108-126

  Tsokos, Maria ^a   Alaggio, Rita D ^b   Dehner, Louis P ^c   Dickman, Paul S ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c BARNES JEWISH HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Desmoplastic small round cell tumor; Ewing sarcoma; EWS gene rearrangement; EWS pPNET; Peripheral primitive neuroectodermal tumor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ANTINEOPLASTIC AGENT; CAVEOLIN 1; DESMIN; HYBRID PROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1; WT1 PROTEIN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE FUSION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MERKEL CELL TUMOR; NERVE CELL DIFFERENTIATION; NEUROECTODERM TUMOR; NONHUMAN; PERIPHERAL PRIMITIVE NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

ADOLESCENT; CHILD; DESMOPLASTIC SMALL ROUND CELL TUMOR; GENE REARRANGEMENT; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; RNA-BINDING PROTEIN EWS; SARCOMA, EWING; YOUNG ADULT;

EID: 84858776346     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/11-08-1078-PB.1     Document Type: Review

References (236)

1. Ewing J. Diffuse endothelioma of bone. Proc NY Pathol Soc 1921; 21:17-24.
2. Ewing J. Further report of endothelial myeloma of bone. Proc NY Pathol Soc 1924;24:93-101.
3. Friedman B, Gold H. Ultrastructure of Ewing's sarcoma of bone. Cancer 1968;22:307-322.
4. Dickman PS, Liotta LA, Triche TJ. Ewing's sarcoma: characterization in established cultures and evidence of its histogenesis. Lab Invest 1982;47:375-382. (Pubitemid 12000763)
5. Kadin ME, Bensch KG. On the origin of Ewing's tumor. Cancer 1971;27:257-273.
6. Sato T, Takahashi K. Electron microscopical study of Ewing's sarcoma: a preliminary report. Recent Adv Res 1975;15:129.
7. Povýsil C, Matjovský Z. Ultrastructure of Ewing's tumour. Virchows Arch A Pathol Anat Histol 1977;374:303-316.
8. Stern R, Wilczek J, Thorpe WP, Rosenberg SA, Cannon G. Procollagens as markers for the cell of origin of human bone tumors. Cancer Res 1980;40:325-328. (Pubitemid 10140157)
9. Yunis EJ. Ewing's sarcoma and related small round cell neoplasms in children. Am J Surg Pathol 1986;10:54-62.
10. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993;17:1-13. (Pubitemid 23011315)
11. Willis RA. Metastatic neuroblastoma in bone presenting the Ewing syndrome, with a discussion of "Ewing's sarcoma". Am J Pathol 1940;16:317-331.
12. Stout AP. A tumor of the ulnar nerve. Proc NY Pathol Soc 1918;2-12.
13. Angervall L, Enzinger FM. Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer 1975;36:240-251.
14. Jaffe R, Santamaria M, Yunis EJ, et al. The neuroectodermal tumor of bone. Am J Surg Pathol 1984;8:885-898. (Pubitemid 15161464)
15. Askin FB, Rosai J, Sibley RK, Dehner LP, McAlister WH. Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer 1979;43:2438-2451. (Pubitemid 9246421)
16. Kaspers GJJL, Kamphorst W, van de Graaff M, van Alphen HAM, Veerman AJP. Primary spinal epidural extraosseous Ewing's sarcoma. Cancer 1991;68:648-654.
17. Jimenez RE, Folpe AL, Lapham RL, et al. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol 2002;26:320-327. (Pubitemid 34184455)
18. Ahmed AA, Nava VE, Pham T, et al. Ewing sarcoma family of tumors in unusual sites: confirmation by RT-PCR. Pediatr Dev Pathol 2006;9:488-495. (Pubitemid 46031176)
19. Dehner LP. Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus. Arch Pathol Lab Med 1986;110:997-1005. (Pubitemid 17170948)
20. Tsokos M. Peripheral primitive neuroectodermal tumors: diagnosis, classification, and prognosis. Perspect Pediatr Pathol 1992;16: 27-98.
21. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-299. (Pubitemid 24236016)
22. Ushigome S, Machinami R, Sorensen PH. Ewing sarcoma/primitive neuroectodermal tumour (PNET). In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002;297-300.
23. Riggi N, Cironi L, Provero P, et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 2005;65:11459-11468. (Pubitemid 41821703)
24. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord L, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007;11:421-429. (Pubitemid 46680428)
25. Turc-Carel C, Philip I, Berger M-P, Philip T, Lenoir GM. Chromosome study of Ewing's sarcoma (ES) cell lines: consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet Cytogenet 1984;12:1-10.
26. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984;311:584-585. (Pubitemid 15189210)
27. Barr FG, Womer RB. Molecular diagnosis of Ewing family tumors: too many translocations... ? J Mol Diagn 2007;9:437-440. (Pubitemid 47434109)
28. Ries L, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda: National Cancer Institute, 2006.
29. Meister P, Gokel JM. Extraskeletal Ewing's sarcoma. Virchow Arch Pathol Anat [A] 1978;378:173-179. (Pubitemid 8335585)
30. Das L, Chang CH, Cushing B, Jewell P. Congenital primitive neuroectodermal tumor (neuroepithelioma) of the chest wall. Med Pediatr Oncol 1982;10:349-358. (Pubitemid 12065733)
31. Gonzalez-Crussi F, Wolfson SL, Misugi K, Nakajima T. Peripheral neuroectodermal tumors of the chest wall in childhood. Cancer 1984;54:2519-2527. (Pubitemid 15223398)
32. Shimada H, Newton WA, Soule EH, Qualman SJ, Aoyama C, Maurer HM. Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Hum Pathol 1988;19:442-453.
33. Coffin CM, Dehner LP. Peripheral neurogenic tumors of the soft tissues in children and adolescents: a clinicopathologic study of 139 cases. Pediatr Pathol 1989;9:387-407. (Pubitemid 19228775)
34. Rud NP, Reiman HM, Pritchard DJ, Frassica FJ, Smithson WA. Extraosseous Ewing's sarcoma: a study of 42 cases. Cancer 1989; 64:1548-1553. (Pubitemid 19238978)
35. Kushner BH, Hajdu SI, Gulati SC, Erlandson RA, Exelby PR, Lieberman PH. Extracranial primitive neuroectodermal tumors: the Memorial Sloan-Kettering Cancer Center experience. Cancer 1991; 67:1825-1829.
36. Schmidt D, Herrmann C, Jurgens H, Harms D. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma: a report from the Kiel Pediatric Tumor Registry. Cancer 1991;68:2251-2259.
37. Maygarden SJ, Askin FB, Siegal GP, et al. Ewing sarcoma of bone in infants and toddlers: a clinicopathologic report from the Intergroup Ewing's Study. Cancer 1993;71:2109-2118. (Pubitemid 23068563)
38. Kyriakos M, Coffin CM, Swanson PE. Diagnostic challenges in soft tissue pathology: a clinicopathologic review of selected lesions. In: Weidner N, ed. The Difficult Diagnosis in Surgical Pathology. Philadelphia: W.B. Saunders, 1996.
39. Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2010;116:983-988.
40. Raney RB, Asmar L, Newton WA Jr, et al. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997;15:574-582. (Pubitemid 27074224)
41. Gururangan S, Marina NM, Luo X, et al. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. J Pediatr Hematol Oncol 1998;20:55-61. (Pubitemid 28119757)
42. Castex MP, Rubie H, Stevens MCG, et al. Extraosseous localized Ewing tumours: improved outcome with anthracyclines. The French Society of Pediatric Oncology and International Society of Pediatric Oncology. J Clin Oncol 2007;25:1176-1182. (Pubitemid 46640563)
43. Hashimoto H, Enjoji M, Nakajima T, Kiryu H, Daimaru Y. Malignant neuroepithelioma (peripheral neuroblastoma): a clinicopathologic study of 15 cases. Am J Surg Pathol 1983;7:309-318. (Pubitemid 13072083)
44. Schmidt D, Harms D, Burdach S. Malignant peripheral neuroectodermal tumors of childhood and adolescence. Virchows Arch A 1985;406:351-365. (Pubitemid 15042742)
45. Nesbitt KA, Vidone RA. Primitive neuroectodermal tumor (neuroblastoma) arising in sciatic nerve of a child. Cancer 1976; 37:1562-1570.
46. Linnoila RI, Tsokos M, Triche TJ, Marangos PJ, Chandra RS. Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor"). Am J Surg Pathol 1986;10:124-133. (Pubitemid 16103163)
47. Shinoda M, Tsutsumi Y, Hata JI, Yokoyama S. Peripheral neuroepithelioma in childhood: immunohistochemical demonstration of epithelial differentiation. Arch Pathol Lab Med 1988;112: 1155-1158. (Pubitemid 18266535)
48. Contesso G, Llombart-Bosch A, Terrier P, et al. Does malignant small round cell tumor of thoracopulmonary origin (Askin tumor) constitute a clinicopathologic entity? Cancer 1992;69:1012-1020.
49. Bolen JW, Thorning D. Peripheral neuroepithelioma: a light and electron microscopic study. Cancer 1980;46:2456-2462. (Pubitemid 11253707)
50. Harper PG, Pringle J, Souhami RL. Neuroepithelioma: a rare malignant peripheral nerve tumor of primitive origin. Report of two new cases and a review of the literature. Cancer 1981;48:2282-2287. (Pubitemid 12231604)
51. Zoubek A, Simonitsch I, Panzer-Grümayer ER, et al. Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma: therapyassociated secondary neoplasm or unrelated coincidence? Cancer Genet Cytogenet 1995;83:5-11.
52. Spunt SL, Rodriguez-Galindo C, Fuller CE, et al. Ewing sarcomafamily tumors that arise after treatment of primary childhood cancer. Cancer 2006;107:201-206. (Pubitemid 43939048)
53. Pappo AS, Cheah MSC, Saldivar VA, Britton HA, Parmley RT. Disseminated primitive neuroectodermal tumor: diagnosis using immunocytochemistry, electron microscopy, and molecular probes. Cancer 1989;63:2515-2521. (Pubitemid 19152765)
54. Llombart-Bosch A, Terrier-Lacombe MJ, Peydro-Olaya A, Contesso G. Peripheral neuroectodermal sarcoma of soft tissue (peripheral neuroepithelioma): a pathologic study of ten cases with differential diagnosis regarding other small, round-cell sarcomas. Hum Pathol 1989;20:273-280. (Pubitemid 19081965)
55. Seemayer TA, Thelmo WL, Bolande RP, Wigglesworth FW. Peripheral neuroectodermal tumors. Perspect Pediatr Pathol 1975; 2:151-172.
56. Granowetter L, Womer R, Devidas M, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol 2009;27:2536-2541.
57. Schuck A, Hofmann J, Rübe C, et al. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92. Int J Radiat Oncol Biol Phys 1998;42: 1001-1006. (Pubitemid 29004141)
58. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55:168-177. (Pubitemid 36020356)
59. Dunst J, Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer 2004;42:465-470. (Pubitemid 38524480)
60. Soule EH, Newton W, Moon TE, Tefft M. Extraskeletal Ewing's sarcoma: a preliminary review of 26 cases encountered in the Intergroup Rhabdomyosarcoma Study. Cancer 1978;42:259-264. (Pubitemid 9031875)
61. Dickman PS, Triche TJ. Extraosseous Ewing's sarcoma versus primitive rhabdomyosarcoma: diagnostic criteria and clinical correlation. Hum Pathol 1986;17:881-893. (Pubitemid 17184313)
62. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 2005;29:1025-1033. (Pubitemid 41045546)
63. Cavazzana AO, Ninfo V, Roberts J, Triche TJ. Peripheral neuroepithelioma: a light microscopic, immunocytochemical, and ultrastructural study. Mod Pathol 1992;5:71-78.
64. Dickman PS. Ewing's sarcoma/primitive neuroectodermal tumor. Pathol Case Rev 2000;5:60-70.
65. Triche TJ, Ross WE. Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma. Cancer 1978;41:1425-1432. (Pubitemid 8330424)
66. Yunis EJ, Agostini RM Jr, Walpusk JA, Hubbard JD. Glycogen in neuroblastomas: a light- and electron-microscopic study of 40 cases. Am J Surg Pathol 1979;3:313-323. (Pubitemid 9228786)
67. Kissane JM, Askin FB, Foulkes M, Stratton LB, Shirley SF. Ewing's sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing's Sarcoma Study. Hum Pathol 1983;14:773-779. (Pubitemid 13001764)
68. Nascimento AG, Unni KK, Pritchard DJ, Cooper DL, Dahlin DC. A clinicopathologic study of 20 cases of large cell (atypical) Ewing's sarcoma of bone. Am J Clin Pathol 1980;4:29-36. (Pubitemid 10176069)
69. Hasegawa T, Hirose T, Kudo E, Hizawa K, Yamawaki S, Ishii S. Atypical primitive neuroectodermal tumors: comparative light and electron microscopic and immunohistochemical studies on peripheral neuroepitheliomas and Ewing's sarcomas. Acta Pathol Jpn 1991;41:444-454.
70. Llombart-Bosch A, Machado I, Navarro S, et al. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch 2009;455:397-411.
71. Nakamura Y, Becker LE, Mancer K, Gillespie R. Peripheral medulloepithelioma. Acta Neuropathol 1982;57:137-142. (Pubitemid 12085166)
72. Bridge JA, Fidler ME, Neff JR, et al. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol 1999;23:159-165. (Pubitemid 29075156)
73. Machado I, Noguera R, Mateos EA, et al. The many faces of atypical Ewing's sarcoma: a true entity mimicking sarcomas, carcinomas and lymphomas. Virchows Arch 2011;458:281-290.
74. Llombart-Bosch A, Peydro-Olaya A, Gomar F. Ultrastructure of one Ewing's sarcoma of bone with endothelial character and a comparative review of the vessels in 27 cases of typical Ewing's sarcoma. Pathol Res Pract 1980;167:71-87. (Pubitemid 10071566)
75. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteosarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative therapy. Cancer 1982;49:1221-1230. (Pubitemid 12187826)
76. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84. (Pubitemid 27020560)
77. Daugaard S, Kamby C, Sunde LM, Myrhe-Jensen O, Schiodt T. Ewing's sarcoma: a retrospective study of histological and immunohistochemical factors and their relation to prognosis. Virchows Arch Pathol Anat [A] 1989;414:243-251. (Pubitemid 19069743)
78. Picci P, Böhling T, Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997;15:1553-1559. (Pubitemid 27167392)
79. Schoedel K, Dickman PS, Krailo M, Perlman EJ, Miser J, Grier H. Histologic response to chemotherapy and prognosis in osseous Ewing's sarcoma/primitive neuroectodermal tumor (EWS/pPNET) (abstract). Int J Surg Pathol 1995;2:443.
80. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 2000;18:4-11. (Pubitemid 30036330)
81. Dickman PS, Askin FB. Histopathology of Ewing's sarcoma/primitive neuroectodermal tumor (EWS/pPNET) after chemotherapy: the alveolar-rosette pattern (abstract). Lab Invest 1992;66:5A.
82. Schmidt D, Mackay B, Ayala AG. Ewing's sarcoma with neuroblastoma-like features. Ultrastruct Pathol 1982;3:143-151. (Pubitemid 12025525)
83. Peydró-Olaya A, Llombart-Bosch A, Carda-Batalla C, Lopez-Guerrero JA. Electron microscopy and other ancillary techniques in the diagnosis of small round cell tumors. Semin Diagn Pathol 2003;20:25-45. (Pubitemid 36378626)
84. Franchi A, Pasquinelli G, Cenacchi G, et al. Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma/PNET of bone and soft tissues. Ultrastruct Pathol 2001; 25:219-25. (Pubitemid 32607295)
85. Srivastava A, Rosenberg AE, Selig M, Rubin BP, Nielsen GP. Keratin-positive Ewing's sarcoma: an ultrastructural study of 12 cases. Int J Surg Pathol 2005;13:43-50. (Pubitemid 40224096)
86. Schuetz AN, Rubin BP, Goldblum JR, et al. Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation. Mod Pathol 2005;18:1403-1410. (Pubitemid 41509393)
87. Kovar H, Dworzak M, Strehl S, et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 1990;5:1067-1070.
88. Cerisano V, Aalto Y, Perdichizzi S, et al. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene 2004;23:5664-5674. (Pubitemid 39093044)
89. Schenkel AR, Dufour EM, Chew TW, Sorg E, Muller WA. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response. Cell Commun Adhes 2007;14:227-237.
90. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;139:317-325.
91. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ETS gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991;5:908-918. (Pubitemid 21906006)
92. Llombart-Bosch A, Navarro S. Immunohistochemical detection of EWS and FLI-1 proteins in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol 2001;9:255-260. (Pubitemid 32783049)
93. Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24:1657-1662.
94. Mhawech-Fauceglia P, Herrmann F, Penetrante R, et al. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/pPNET): a comparative study with CD99 and FLI-1 polyclonal antibodies. Histopathology 2006;49:569-575. (Pubitemid 44924288)
95. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 2001;25:1061-1066. (Pubitemid 32685904)
96. Tirado OM, Mateo-Lozano S, Villar J, et al. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res 2006;66:9937-9947. (Pubitemid 44672046)
97. Pinto A, Grant LH, Hayes FA, Schell MJ, Parham DM. Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone. Cancer 1989;64:1266-1273. (Pubitemid 19217105)
98. Ladanyi M, Heinemann FS, Huvos AG, Rao PH, Chen QG, Jhanwar SC. Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases. Hum Pathol 1990;21: 1245-1251.
99. Collini P, Sampietro G, Bertulli R, et al. Cytokeratin immunoreactivity in 41 cases of EWS/pPNET confirmed by molecular diagnostic studies. Am J Surg Pathol 2001;25:273-274. (Pubitemid 32167512)
100. Gu M, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol 2000;24:410-416. (Pubitemid 30127477)
101. Parham DM, Dias P, Kelly DR, Rutledge JC, Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992;16:483-492.
102. Barisella M, Collini P, Orsenigo M, et al. Unusual myogenic and melanocytic differentiation of soft tissue pPNETs: an immunohistochemical and molecular study of 3 cases. Am J Surg Pathol 2010; 34:1002-1006.
103. Boué DR, Parham DM, Webber B, et al. Clinicopathologic study of ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV. Pediatr Dev Pathol 2000;3:290-300. (Pubitemid 30232857)
104. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25:396-399. (Pubitemid 24151126)
105. Dei Tos AP, Wadden C, Calonje E et al. Immunohistochemical demonstration of glycoprotein p30/32 (MIC2) (CD99) in synovial sarcoma: a potential cause of diagnostic confusion. Appl Immunohistochem 1995;3:168-173.
106. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22:673-682. (Pubitemid 28280269)
107. Romansky SG, Crocker DW. Neuroblastoma. Prog Surg Pathol 1983;5:67-99.
108. Jurgens H, Bier V, Harms D, et al. Malignant peripheral neuroectodermal tumors: a retrospective analysis of 42 patients. Cancer 1988;61:349-357. (Pubitemid 18056495)
109. Buckley SL, Burkus JK, Blasier RB. Malignant neuroepithelioma (peripheral neuroblastoma): a case report. Clin Orthop 1989;243: 220-224. (Pubitemid 19165390)
110. Marina NM, Etcubanas E, Parham DM, Bowman LC, Green A. Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children: a review of the St. Jude experience and controversies in diagnosis and management. Cancer 1989;64:1952-1960. (Pubitemid 19267818)
111. Ehrig T, Billings SD, Fanburg-Smith JC. Superficial primitive neuroectodermal tumor/Ewing sarcoma (PN/ES): same tumor as deep PN/ES or new entity? Ann Diagn Pathol 2007;11:153-159. (Pubitemid 46694379)
112. Hasegawa SL, Davison JM, Rutten A, Fletcher JA, Fletcher CD. Primary cutaneous Ewing's sarcoma: immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol 1998;22:310-318. (Pubitemid 28108412)
113. Nicholson SA, McDermott MB, Swanson PE, Wick MR. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 2000;8:37-41. (Pubitemid 30152352)
114. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33:984-991.
115. Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA. Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer 2007;49:1015-1017. (Pubitemid 350022467)
116. Ellison DA, Parham DM, Bridge J, Beckwith JB. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol 2007;38:205-211. (Pubitemid 46096565)
117. Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith JB. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol 2001;25:133-146. (Pubitemid 32167495)
118. Romeo S, Dei Tos AP. Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 2010;456:219-234.
119. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol 2007;31:1813-1824. (Pubitemid 350175808)
120. Fanburg-Smith JC, Dal Cin P. Angiomatoid fibrous histiocytoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone, Lyon: IARC Press. 2002;194-195.
121. Turc-Carel C, Philip I, Berger M-p, Philip T, Lenoir GM. Chromosomal translocations in Ewing's sarcoma. N Engl J Med 1983;390:496-497.
122. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A. Chromosomal translocations in Ewing's sarcoma. N Engl J Med 1983;309:496-497.
123. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-165.
124. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993;12:4481-4487. (Pubitemid 23330254)
125. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994;6:146-151. (Pubitemid 24188594)
126. Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 2007;9:498-509. (Pubitemid 47434117)
127. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996; 14:1245-1251. (Pubitemid 26105532)
128. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003;63:4568-4576. (Pubitemid 36951031)
129. Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007;9:459-463. (Pubitemid 47434112)
130. Mastrangelo T, Modena P, Tornielli S, et al. A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 2000; 19:3799-3804. (Pubitemid 30621186)
131. Yamaguchi S, Yamazaki Y, Ishikawa Y, Kawaguchi N, Mukai H, Nakamura T. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosomes Cancer 2005; 43:217-222. (Pubitemid 40570743)
132. Szuhai K, Ijszenga M, de Jong D, Karsaladze A, Tanke HJ, Hogendoorn PC. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res 2009;15:2259-2268.
133. Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA. A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol 2011;24:333-342.
134. Thompson AD, Teitell MA, Arvand A, Denny CT. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 1999;18:5506-5513. (Pubitemid 29481497)
135. May WA, Gishizky ML, Lessnick SL, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 1993;90:5752-5756. (Pubitemid 23176240)
136. Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle 2006;5: 2753-2759. (Pubitemid 44901737)
137. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors. Cancer Res 2005;65:8698-8705. (Pubitemid 41377357)
138. Deneen B, Denny CT. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 2001;20:6731-6741. (Pubitemid 33020602)
139. Lessnick SL, Dacwag CS, Golub TR. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 2002;1:393-401. (Pubitemid 41039140)
140. Miyagawa Y, Okita H, Nakaijima H, et al. Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol 2008;28:2125-2137. (Pubitemid 351429961)
141. Riggi N, Suvà ML, Suvà D, et al. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 2008;68:2176-2185. (Pubitemid 351521790)
142. Riggi N, Suvà ML, De Vito C, et al. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 2010;24:916-932.
143. May WA, Lessnick SL, Braun BS, et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 1993;13:7393-7398. (Pubitemid 23354263)
144. Hancock JD, Lessnick SL. A transcriptional profiling metaanalysis reveals a core EWS-FLI gene expression signature. Cell Cycle 2008;7:250-256. (Pubitemid 351366526)
145. Jedlicka P. Ewing sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int J Clin Exp Pathol 2010;3:338-347.
146. Kauer M, Ban J, Kofler R, et al. A molecular function map of Ewing's sarcoma. PLoS One 2009;4:e5415.
147. Bailly RA, Bosselut R, Zucman J, et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 1994;14:3230-3241. (Pubitemid 24132736)
148. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 1994;269:18216-18222. (Pubitemid 24206223)
149. Gangwal K, Sankar S, Hollenhorst PC, et al. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci USA 2008;105:10149-10154.
150. Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O. The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One 2009;4:e4932.
151. Torchia EC, Jaishankar S, Baker SJ. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res 2003;63:3464-3468. (Pubitemid 36793021)
152. Teitell MA, Thompson AD, Sorensen PH, Shimada H, Triche TJ, Denny CT. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts. Lab Invest 1999; 79:1535-1543. (Pubitemid 30013918)
153. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 2005;65:4633-4644. (Pubitemid 40740799)
154. Staege MS, Hutter C, Neumann I, et al. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 2004;64:8213-8221. (Pubitemid 39491758)
155. Riggi N, Suvà ML, Stamenkovic I. Ewing's sarcoma origin: from duel
156. Lee G, Kim H, Elkabetz Y, et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 2007;25:1468-1475. (Pubitemid 350233140)
157. Takashima Y, Era T, Nakao K, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129: 1377-1388. (Pubitemid 46970707)
158. Roberts P, Burchill SA, Brownhill S, et al. Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. Genes Chromosomes Cancer 2008;47:207-220. (Pubitemid 351162852)
159. Savola S, Klami A, Tripathi A, et al. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer 2009;9:17.
160. Burchill SA. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol 2003; 56:96-102. (Pubitemid 36177250)
161. Huang HY, Illei PB, Zhao Z, et al. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 2005;23: 548-558. (Pubitemid 46224232)
162. Honoki K, Stojanovski E, McEvoy M, et al. Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysis. Cancer 2007;110:1351-1360. (Pubitemid 47435609)
163. Brownhill SC, Taylor C, Burchill SA. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. Br J Cancer 2007;96:1914-1923. (Pubitemid 46912030)
164. Savola S, Nardi F, Scotlandi K, Picci P, Knuutila S. Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma. Cytogenet Genome Res 2007;119:21-26.
165. DuBois SG, Grier HE, Lessnick SL. Ewing's sarcoma. In: Orkin SH, Fisher DE, Look AT, Lux SE IV, Ginsburg D, Nathan DG, eds. Oncology of Infancy and Childhood. Philadelphia: Saunders/Elsevier, 2009;829-869.
166. Womer RB, West DC, Krailo MD, Dickman PS, Pawel B, for the Children's Oncology Group AEWS0031 Committee. Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family tumors. J Clin Oncol 2008;26:10504.
167. Terrier-Lacombe MJ, Guillou L, Chibon F, et al. Superficial primitive Ewing's sarcoma: a clinicopathologic and molecular cytogenetic analysis of 14 cases. Mod Pathol 2009;22:87-94.
168. Pinto A, Dickman P, Parham D. Pathobiologic markers of the Ewing sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma 2011;2011:856190.
169. Parham DM, Hijazi Y, Steinberg SM, et al. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. Hum Pathol 1999;30:911-918. (Pubitemid 29380514)
170. Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004;40:73-83. (Pubitemid 37542320)
171. Bacci G, Longhi A, Ferrari S, Mercuri M, Yersari M, Bertoni F. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006;45:469-475. (Pubitemid 43884616)
172. van Doorninck JA, Ji L, Schaub B, et al. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol 2010;28:1989-1994.
173. Le Deley MC, Delattre O, Schaefer KL, et al. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol 2010;28:1982-1988.
174. Kovar H, Aryee DN, Jug G, et al. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ 1996;7:429-437. (Pubitemid 26362087)
175. Chansky HA, Barahmand-Pour F, Mei Q, et al. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. J Orthop Res 2004;22:910-917. (Pubitemid 38756277)
176. Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res 2005;65: 8984-8992. (Pubitemid 41377390)
177. Lambert G, Bertrand JR, Fattal E, et al. EWS-FLI1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice. Biochem Biophys Res Commun 2000;279:401-406. (Pubitemid 32016729)
178. Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. EWS-FLI1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 1997;99:239-247. (Pubitemid 27053464)
179. Gerald WL, Rosai J. Case 2. Desmoplastic small cell tumor with divergent differentiation. Pediatr Pathol 1989;9:177-183. (Pubitemid 19157651)
180. Ordóñez NG, Zirkin R, Bloom RE. Malignant small-cell epithelial tumor of the peritoneum coexpressing mesenchymal-type intermediate filaments. Am J Surg Pathol 1989;13:413-421. (Pubitemid 19134072)
181. Gonzalez-Crussi F, Crawford SE, Sun CCJ. Intraabdominal desmoplastic small-cell tumors with divergent differentiation: observations on three cases of childhood. Am J Surg Pathol 1990;14:633-642. (Pubitemid 20203352)
182. Variend S, Gerrard M, Norris PD, et al. Intraabdominal neuroectodermal tumor of childhood with divergent differentiation. Histopathology 1991;18:45-51.
183. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J. Intra-abdominal desmoplastic small round-cell tumor: report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 1991;15:499-513.
184. Ordóñez NG, El-Naggar AK, Ro JY, et al. Intraabdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol 1993;24:850-865. (Pubitemid 23238964)
185. Parkash V, Gerald WL, Parma A, Miettinen M, Rosai J. Desmoplastic small round cell tumor of the pleura. Am J Surg Pathol 1995;19:659-665.
186. Young RH, Eichhorn JH, Dickersin GR, Scully RE. Ovarian involvement by the intra-abdominal desmoplastic small round cell tumor with divergent differentiation: a report of three cases. Hum Pathol 1992;23:454-464.
187. Kretschmar CS, Colbach C, Bhan I, Crombleholme TM. Desmoplastic small cell tumor: a report of three cases and a review of the literature. J Pediatr Hematol Oncol 1996;18:293-298. (Pubitemid 26249505)
188. Tison V, Cerasoli S, Morigi F, Ladanyi M, Gerald WL, Rosai J. Intracranial desmoplastic small-cell tumor: report of a case. Am J Surg Pathol 1996;20:112-117. (Pubitemid 26007717)
189. Cummings OW, Ulbright TM, Young RH, Dei Tos AP, Fletcher CD, Hull MT. Desmoplastic small round cell tumors of the paratesticular region: a report of six cases. Am J Surg Pathol 1997; 21:219-225. (Pubitemid 27084063)
190. Gerald WL, Ladanyi M, de Alava E, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol 1998;16:3028-3036. (Pubitemid 28417423)
191. Adsay V, Cheng J, Athanasian E, Gerald W, Rosai J. Primary desmoplastic small cell tumor of soft tissues and bone of the hand. Am J Surg Pathol 1999;23:1408-1413. (Pubitemid 29517335)
192. Wolf AN, Ladanyi M, Pauli G, Blaugrund JE, Westra WH. The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation. Hum Pathol 1999;30:430-435. (Pubitemid 29177823)
193. Lae ME, Roche PC, Jin L, et al. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 2002;26:823-835. (Pubitemid 34747636)
194. Syed S, Haque AK, Hawkins HK, Sorensen PHB, Cowan DF. Desmoplastic small round cell tumor of the lung. Arch Pathol Lab Med 2002;126:1226-1228. (Pubitemid 36236617)
195. Bismar TA, Basturk O, Gerald WL, et al. Desmoplastic small cell tumor in the pancreas. Am J Surg Pathol 2004;28:808-812. (Pubitemid 38685896)
196. Wang LL, Perlman EJ, Vujanic GM, et al. Desmoplastic small round cell tumor of the kidney in childhood. Am J Surg Pathol 2007;31:576-584. (Pubitemid 46569042)
197. La Quaglia MP, Brennan MF. The clinical approach to desmoplastic small round cell tumor. Surg Oncol 2000;9:77-81.
198. Gil A, Gomez Portilla A, Brun EA, Sugarbaker PH. Clinical perspective on desmoplastic small round-cell tumor. Oncology 2004;67:231-242. (Pubitemid 39551707)
199. Amato RJ, Ellerhorst JA, Ayala AG. Intraabdominal desmoplastic small round cell tumor: report and discussion of five cases. Cancer 1996;78:845-851. (Pubitemid 26268616)
200. Dorsey BV, Benjamin LE, Rauscher F III, et al. Intra-abdominal desmoplastic small round cell tumor: expansion of the pathologic profile. Mod Pathol 1996;9:703-709. (Pubitemid 26227575)
201. Smith ME, Pelletier JP, Daniels R. Pathologic quiz case: intraabdominal desmoplastic small round cell tumor. Arch Pathol Lab Med 2000;124:1839-1840.
202. Ordóñez NG. Desmoplastic small round cell tumor: I. A histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol 1998;22:1303-1313. (Pubitemid 28499121)
203. Ordóñez NG. Desmoplastic small round cell tumor: II. An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998;22:1314-1327. (Pubitemid 28499122)
204. Wills EJ. Peritoneal desmoplastic small round cell tumors with divergent differentiation: a review. Ultrastruct Pathol 1993;17: 295-306. (Pubitemid 23297838)
205. Sawyer JR, Tryka AF, Lewis JM. A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol 1992;16:411-416.
206. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994;54:2837-2840. (Pubitemid 24187757)
207. de Alava E, Ladanyi M, Rosai J, Gerald WL. Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by polymerase chain reaction: a specific diagnostic assay. Am J Pathol 1995;147:1584-1591.
208. Barr FG, Chatten J, D'Cruz, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995;273:553-557.
209. Antonescu CR, Gerald WL, Magid MS, Ladanyi M. Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor. Diagn Mol Pathol 1998;7:24-28. (Pubitemid 28285807)
210. Chan AS, MacNeill S, Thorner P, et al. Variant EWS-WT1 chimeric product in the desmoplastic small round cell tumor. Pediatr Dev Pathol 1999;2:188-192. (Pubitemid 29130206)
211. Liu J, Nau MM, Yeh JC, et al. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Clin Cancer Res 2000;6:3522-3529.
212. Murphy AJ, Bishop K, Pereira C, et al. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity. Hum Pathol 2008;39:1763-1770.
213. Lee YS, Hsiao CH. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical molecular study of four patients. J Formos Med Assoc 2007;106:854-860. (Pubitemid 350104280)
214. Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 2003;16:229-235. (Pubitemid 36337429)
215. Alaggio R, Boldrini R, Di Venosa B, Rosolen A, Bisogno G, Magro G. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies. Pathol Res Pract 2009;205:451-457.
216. Lal DR, Su WT, Wolden SL, et al. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg 2005;40:251-255. (Pubitemid 40143567)
217. Saab R, Khoury JD, Krasin M, et al. Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer 2007;49:274-279. (Pubitemid 47236216)
218. Kushner BH, La Quaglia MP, Wollner N et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996;14:1526-1531. (Pubitemid 26134209)
219. Mazuryk M, Paterson AH, Temple W, et al. Benefit of aggressive multimodality therapy with autologous stem cell support for intraabdominal desmoplastic small round cell tumor. Bone Marrow Transplant 1998;21:961-963. (Pubitemid 28200868)
220. Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep 2006;8: 310-315. (Pubitemid 43970983)
221. Fraser CJ, Weigel BJ, Perentesis JP, et al. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors. Bone Marrow Transplant 2006;37:175-181. (Pubitemid 43108810)
222. Ferrari A, Grosso F, Stacchiotti S, et al. Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor. Pediatr Blood Cancer 2007;49:864-866. (Pubitemid 47519531)
223. Gerald WL, Haber DA. The EWS-WT1 gene fusion in desmoplastic small round cell tumor (review). Semin Cancer Biol 2005;15:197-205.
224. Kim J, Lee K, Pelletier J. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct. Oncogene 1998;16:1021-1030. (Pubitemid 28107940)
225. Kim J, Lee K, Pelletier J. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Oncogene 1998;16:1973-1979. (Pubitemid 28200609)
226. Kim J, Lee JM, Branton PE, Pelletier J. Modification of EWS/WT1 functional properties by phosphorylation. Proc Natl Acad Sci USA 1999;96:14300-14305. (Pubitemid 30000645)
227. Karnieli E, Werner H, Rauscher FJ 3rd, et al. The IGI-I receptor gene promotor is a molecular target for the Ewing's sarcoma Wilms' tumor 1 fusion protein. J Biol Chem 1996;271:19304-19309. (Pubitemid 26271599)
228. Lee SB, Kolquist KA, Nichols K, et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat Genet 1997;17:309-313. (Pubitemid 27475994)
229. Li H, Smolen GA, Beers LF, et al. Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor. PLoS One 2008;3:e2353.
230. Seppä H, Grotendorst G, Seppä S, Schiffmann E, Martin GR. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 1982;92:584-588. (Pubitemid 12157432)
231. Rachfal AW, Luquette MH, Brigstock DR. Expression of connective tissue growth factor (CCN2) in domestic small round cell tumour. J Clin Pathol 2004;57:422-425. (Pubitemid 38446263)
232. Adamson PC, Blaney SM, Widemann BC, et al. Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother Pharmacol 2004;53:482-488. (Pubitemid 38680245)
233. George S, Merriam P, Maki RG, et al. Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 2009;27:3154-3160.
234. Bond M, Bernstein ML, Pappo A, et al. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group Study. Pediatr Blood Cancer 2008;50:254-258.
235. Sankhala KK, Chawla SP. Review: desmoplastic small round cell tumor: current treatment approach and role of targeted therapy. Clin Adv Hematol Oncol 2009;7:476-478.
236. Modak S, GeraldW, Cheung NK. Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor. Med Pediatr Oncol 2002;39:547-551. (Pubitemid 35191435)